Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Other Accumulated Expenses: 2011-2025

Historic Other Accumulated Expenses for Alkermes (ALKS) over the last 14 years, with Sep 2025 value amounting to $79.8 million.

  • Alkermes' Other Accumulated Expenses rose 18.63% to $79.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.8 million, marking a year-over-year increase of 18.63%. This contributed to the annual value of $68.7 million for FY2024, which is 25.12% down from last year.
  • Alkermes' Other Accumulated Expenses amounted to $79.8 million in Q3 2025, which was down 11.34% from $90.0 million recorded in Q2 2025.
  • Alkermes' 5-year Other Accumulated Expenses high stood at $117.1 million for Q3 2022, and its period low was $62.5 million during Q1 2021.
  • For the 3-year period, Alkermes' Other Accumulated Expenses averaged around $85.5 million, with its median value being $85.6 million (2024).
  • As far as peak fluctuations go, Alkermes' Other Accumulated Expenses soared by 88.66% in 2021, and later dropped by 25.12% in 2024.
  • Alkermes' Other Accumulated Expenses (Quarterly) stood at $75.5 million in 2021, then surged by 43.23% to $108.2 million in 2022, then dropped by 15.12% to $91.8 million in 2023, then decreased by 25.12% to $68.7 million in 2024, then rose by 18.63% to $79.8 million in 2025.
  • Its Other Accumulated Expenses stands at $79.8 million for Q3 2025, versus $90.0 million for Q2 2025 and $83.1 million for Q1 2025.